A complex story behind genes, environment, diabetes and obesity

August 07, 2013

While it is well known that there is a strong genetic basis to both diabetes and obesity, and that they are linked, Australian researchers say that there are many rare genetic variants involved, which will pose a significant challenge in the quest to develop effective therapies.

Type 2 diabetes is a metabolic disorder that occurs when the body becomes less able to produce and use insulin effectively, a hormone essential for maintaining normal metabolism of food. The disorder is commonly associated with a high-sugar, high-fat diet combined with lack of exercise.

A new study by Professor Lesley Campbell, Director of Diabetes Services at St. Vincent's Hospital and a senior member of Garvan's Diabetes and Obesity Clinical Studies group, in collaboration with Dr Arthur Jenkins and coworkers from the University of Wollongong, shows that many different defects in overweight or obesity genes are involved, most of which are very rare. The findings are published in PLOS ONE, now online.

Over the last 25 years, Professor Campbell has gathered detailed information about over 300 healthy people with a family history of type 2 diabetes, including their body shape, size and composition (using Dual-energy X-ray absorptiometry to obtain accurate measurements). Specifically, her research looks at people who are genetically at risk of developing type 2 diabetes and are overweight or obese before they get the disease.

The information gathered by Professor Campbell was analysed by Dr Jenkins using a specially constructed mathematical model. He concluded that many genes are responsible for obesity, with each affected family likely to tell a slightly different genetic story.

"We can see that there are many, many different ways in which the system can go wrong, with more variety than commonality," said Dr Jenkins.

"In my opinion, the current quest to develop a single anti-obesity drug is misguided - because there are too many potential problems to be targeted by a single drug, or indeed any small number of drugs."

"It's likely that the same is true of type 2 diabetes. The underlying cause is genetic and the genetic causes are very rare, but there are many differences between people."

"Rare genetic defects account for something like 95% of the total problem. That is a very unwelcome fact for most people, who would like to think an easy solution is close at hand."

Professor Campbell stresses that genes bring out underlying predispositions, and there are fairly predictable interactions between genes and environment. So if people are predisposed to a strong appetite, large amounts of easily available, highly palatable, food are likely to make them fat.

"The reason we see so many people getting fat is that they carry strong hunger genes while the environment is maxed; it's an obesogenic environment that rewards eating," said Professor Campbell.

"People no longer have to go fishing, or hunting and gathering in order to eat. They just go to McDonalds, or KFC, or the freezer. The point is that people don't have to expend any energy to get an abundance of food, often high in fat or sugar."

"We have shown in previous studies that people with diabetes in the family tend to be hungry more often, are able to eat more at a sitting, and will generally opt to eat high calorie foods. This does not mean they are 'greedy', it just means that their bodies are genetically driven to eat more."

"The same genes would serve these people well in times of food scarcity or famine. They would survive, while their leaner neighbours would perish."
-end-


Garvan Institute of Medical Research

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.